Clinical data | |
---|---|
ATC code |
|
Pharmacokinetic data | |
Protein binding | ~89% |
Elimination half-life | 2.5–5.5 hours |
Identifiers | |
IUPAC name
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.006.546 |
Chemical and physical data | |
Formula | C9H10N2O3S2 |
Molar mass | 258.31 g·mol−1 |
3D model (JSmol) |
|
SMILES
| |
InChI
| |
(verify) |
Ethoxzolamide (alternatively known as ethoxyzolamide) is a sulfonamide medication that functions as a carbonic anhydrase inhibitor.[1] It is used in the treatment of glaucoma and duodenal ulcers, and as a diuretic. It may also be used in the treatment of some forms of epilepsy.